Gareth J Morgan. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Bone Density Conservation Agents/adverse effectsBone Density Conservation Agents/therapeutic useClodronic Acid/therapeutic useDiphosphonates/adverse effectsDiphosphonates/therapeutic useHumansImidazoles/adverse effectsImidazoles/therapeutic useMultiple Myeloma/complicationsMultiple Myeloma/drug therapyOsteonecrosis/chemically inducedThrombosis/chemically inducedThrombosis/etiologyZoledronic Acid
Substances： See more » Bone Density Conservation AgentsDiphosphonatesImidazolesClodronic AcidZoledronic Acid
Year: 2011 PMID： 21872746 DOI： 10.1016/S0140-6736(11)61374-3
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321